Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Apr 01, 2011 (Vol. 31, No. 7)

BraInSitu

URL:www.nibb.ac.jp/brish/indexE.html
  • ISH protocols
  • Many atlas features "in preparation"

OK, so here’s the “situ”ation—if you enjoy clever portmanteau words, then BraInSitu is right up your alley. (And, oh yeah, if you’re interested in molecular neuroanatomy—that is, the expression patterns of genes in the brain—then you’ll also probably enjoy this site!) BraInSitu is more of an exhibition of various in situ hybridization techniques and specific two- and three-probe combinations, rather than a comprehensive atlas of gene expression, although there are some examples of serial sections stained for various gene markers in the monkey. Many of the genes are listed as “in preparation,” however. (A comparable mouse atlas is also “in preparation.”) One of the more useful aspects of this site is the collection of in situ protocols. There is also a database of probes that have been previously published either by the group behind the website or by others.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »